FDA Action Update, August 2025: Approvals and Complete Response Letter
Neurology Live,
The FDA was busy in August 2025, making a number of decisions on potential new therapeutic agents, including granting approvals…
The FDA was busy in August 2025, making a number of decisions on potential new therapeutic agents, including granting approvals…
The decision stemmed from the DREAM study, which found that the Genio system was effective regardless of a patient’s sleeping…